Pacemaker implantation in a patient with brugada and sick sinus syndrome

• Published in: World journal of cardiology Vol. 5; no. 3; pp. 65 - 67
• Main Authors: Risgaard, Bjarke, Bundgaard, Henning, Jabbari, Reza, Haunsø, Stig, Winkel, Bo Gregers, Tfelt-Hansen, Jacob
• Format: Journal Article
• Language: English
• Published: United States Baishideng Publishing Group Co., Limited 26.03.2013
• Subjects: Arrhythmias; Brugada; cardiac; Case Report; death; Pacemaker; Sudden; syndrome; Brugada syndrome; Sudden cardiac death; Pacemaker; Arrhythmias
• ISSN: 1949-8462; 1949-8462
• DOI: 10.4330/wjc.v5.i3.65

Brugada syndrome (BrS) is a rare and inherited primary arrhythmic syndrome characterized by ST-segment elevations in the right precordial leads (V1 -V3 ) with an increased risk of sudden cardiac death (SCD). Arrhythmias in BrS are often nocturne, and brady-arrhythmias are often seen in patients with loss-of-function mutations in SCN5A . In this case-report we present a 75-year old woman referred to our outpatient clinic for inherited cardiac diseases for a familial clinical work-up. Since childhood she had suffered from dizziness, absence seizures, and countless Syncope’s. In 2004 sick sinus syndrome was suspected and she wastreated with implantation of a pacemaker (PM) at another institution. An inherited cardiac disease was one day suddenly suspected, as the patient had a 61-year old brother who was diagnosed with symptomatic BrS, and treated with an implantable cardioverter defibrillator (ICD) after aborted SCD. A mutation screening revealed a SCN5A [S231CfsX251 (c.692-693delCA )] loss-of-function mutation not previously reported, and as a part of the cascade screening in relatives she was therefore referred to our clinic. In the 7 year period after PM implantation she had experienced no cardiac symptoms, although her electrocardiogram changes now were consistent with a BrS type 1 pattern. A genetic test confirmed that she had the same mutation in SCN5A as her brother. In this case-report we present a loss-of function mutation in SCN5A not previously associated with BrS nor presented in healthy controls. Sinus node dysfunction has previously been documented in patients with symptomatic BrS, which suggests it is not a rare concomitant. The only accepted treatment of BrS is today implantation of an ICD. In the future studies should evaluate if PM in some cases of symptomatic BrS can be used instead of ICDs in patients with a loss-of-function SCN5A mutations